Foresight Capital Management Advisors, Inc. Amgen Inc Transaction History
Foresight Capital Management Advisors, Inc.
- $167 Million
- Q2 2025
A detailed history of Foresight Capital Management Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Foresight Capital Management Advisors, Inc. holds 995 shares of AMGN stock, worth $286,788. This represents 0.17% of its overall portfolio holdings.
Number of Shares
995
Previous 982
1.32%
Holding current value
$286,788
Previous $305,000
9.18%
% of portfolio
0.17%
Previous 0.19%
Shares
3 transactions
Others Institutions Holding AMGN
# of Institutions
3,280Shares Held
427MCall Options Held
7.33MPut Options Held
7.41M-
Vanguard Group Inc Valley Forge, PA52.9MShares$15.2 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.3 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.2MShares$8.41 Billion0.38% of portfolio
-
Capital World Investors Los Angeles, CA16.7MShares$4.81 Billion0.88% of portfolio
-
Morgan Stanley New York, NY16.2MShares$4.68 Billion0.37% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $154B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...